phenylacetic acid and c-peptide

phenylacetic acid has been researched along with c-peptide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunengraber, H; Chandramouli, V; Efendic, S; Landau, BR; Schumann, WC; Wajngot, A	1
Graessler, J; Kopprasch, S; Kuhlisch, E; Pietzsch, J	1

Other Studies

2 other study(ies) available for phenylacetic acid and c-peptide

Article	Year
A probing dose of phenylacetate does not affect glucose production and gluconeogenesis in humans. Metabolism: clinical and experimental, 2000, Volume: 49, Issue:9 Topics: Aged; C-Peptide; Citric Acid Cycle; Deuterium; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Kinetics; Male; Middle Aged; Phenylacetates	2000
Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:4 Topics: Adult; Aged; Aryldialkylphosphatase; C-Peptide; Diabetes Mellitus, Type 2; Esterases; Female; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Phenotype; Phenylacetates; Substrate Specificity	2003

Article

Year

A probing dose of phenylacetate does not affect glucose production and gluconeogenesis in humans.

Metabolism: clinical and experimental, 2000, Volume: 49, Issue:9

Topics: Aged; C-Peptide; Citric Acid Cycle; Deuterium; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Kinetics; Male; Middle Aged; Phenylacetates

2000

Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.

The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:4

Topics: Adult; Aged; Aryldialkylphosphatase; C-Peptide; Diabetes Mellitus, Type 2; Esterases; Female; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Phenotype; Phenylacetates; Substrate Specificity

2003